Month: September 2022

BrightInsight Launches the BrightInsight Ecosystem Bringing Together Leading Healthcare and Technology Companies to Revolutionize Patient Care Through Digital

Leaders From All Facets of Healthcare Will Collaborate to Drive Digital Innovation and Adoption BrightInsight Ecosystem BrightInsight announced today the...

Life sciences leaders share their experiences of scaling transformation at Indegene Digital Summit | September 22-23, 2022 | Virtual-only

Indegene Digital Summit 2022 - Keynote Speakers Keynote speakers at Indegene Digital Summit 2022 - Life Sciences' premier global thought...

TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product

TriLink now offers GMP-grade N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allowing researchers to accelerate their drug discovery and...

Cidara Therapeutics Announces Initiation of Phase 2a Human Viral Challenge Trial to Evaluate CD388 for Universal Prevention of Influenza

CD388 is a drug-Fc conjugate (DFC) from Cidara’s Cloudbreak® platform designed to help transform the standard of care for seasonal...

Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),...

error: Content is protected !!